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Abstract
Background: Low adiponectin, a well-recognized antidiabetic adipokine, has been associated with obesity-related
inflammation, oxidative stress and insulin resistance. Globular adiponectin is an important regulator of the interleukin-1
receptor-associated kinase (IRAK)/NFkB pathway in monocytes of obese subjects. It protects against inflammation and
oxidative stress by inducing IRAK3. microRNA (miR)-146b-5p inhibits NFkB-mediated inflammation by targeted repression of
IRAK1 and TNF receptor-associated factor-6 (TRAF6). Therefore, we measured the expression of miR-146b-5p in monocytes
of obese subjects. Because it was low we determined the involvement of this miR in the anti-inflammatory, antioxidative
and insulin signaling action of globular adiponectin.
Methods: miR-146b-5p expression in monocytes of obese subjects was determined by qRT-PCR. The effect of miR-146b-5p
silencing on molecular markers of inflammation, oxidative stress and insulin signaling and the association with globular
adiponectin was assessed in human THP-1 monocytes.
Results: miR-146b-5p was downregulated in monocytes of obese persons. Low globular adiponectin decreased miR-146b-
5p and IRAK3 in THP-1 monocytes, associated with increased mitochondrial reactive oxygen species (ROS). Intracellular ROS
and insulin receptor substrate-1 (IRS1) protein were unchanged. Silencing of miR-146b-5p with an antisense inhibitor
resulted in increased expression of IRAK1 and TRAF6 leading to more NFkB p65 DNA binding activity and TNFa.A sa
response IRAK3 and IRS1 protein increased. Mitochondrial and intracellular ROS production did not increase despite more
inflammation. In addition, exposure of miR-146b-5p-depleted THP-1 monocytes to high levels of globular adiponectin
resulted in an increased production of TNFa and intracellular ROS. Still, they did not lose their potential to increase IRAK3
and IRS1 protein and to decrease mitochondrial ROS.
Conclusion: miR-146b-5p, decreased in monocytes during obesity, is a major mediator of the anti-inflammatory action of
globular adiponectin. It appears not to be involved in insulin signaling possibly by protective response of IRAK3 and lack of
mitochondrial ROS production.
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Introduction
Over the past decade, it has become quite clear that chronic,
low-grade inflammation and oxidative stress play a key role in the
initiation, propagation and development of obesity and associated
metabolic disorders like insulin resistance, type 2 diabetes,
metabolic syndrome and cardiovascular disease [1–5]. Maladap-
tive production of various adipokines (e.g. adiponectin, resistin,
visfatin, and leptin), and monocyte migration and subsequent
transformation into macrophages within diseased tissues are key
factors in the self-perpetuating inflammation associated with
metabolic disorders [6,7]. In particular, plasma levels of
adiponectin are significantly lower in obese individuals and have
been associated with inflammation, insulin resistance and the
development of cardiovascular disease. Adiponectin is present in
the plasma in its full length, forming homomultimers, and as
globular adiponectin, a shorter product formed by macrophage-
dependent elastase cleavage [8]. Globular adiponectin appears to
be responsible for most biological effects of adiponectin [9,10].
The protective effect of adiponectin has been attributed to its anti-
inflammatory action [11].
T h ei n c r e a s e da d i p o s et i s s u em a c r o p h a g ep o p u l a t i o n sd u r i n g
obesity require an influx of circulating monocytes. Indeed, obesity is
associated with increased levels of blood monocytes [12,13], which
are already activated in the circulation and are characterized by an
increase in NFkB activity, an increase in the transcription of pro-
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increase in the production of reactive oxygen species (ROS)[14]. Our
lab has previously shown that obesity-associated low levels of globular
adiponectin decreases the expression of interleukin-1 receptor-
associated kinase-3 (IRAK3) in monocytes [15]. IRAK3is exclusively
expressed in monocytes/macrophages, acts as an inhibitor of the
IRAK/NFkB-mediated inflammation and is necessary for the anti-
inflammatory and antioxidative action of globular adiponectin. Low
levels of IRAK3 in monocytes are associated with increased
production of TNFa and ROS despite the increase in mitochondrial
antioxidant superoxide dismutase-2 (SOD2) [15]. The increased produc-
tion of mitochondrial ROS (mROS) in monocytes induces insulin
resistance at the molecular level facilitating the development of
diabetes and atherosclerosis [16–19].
microRNAs (miRs) are a class of small endogenous non-coding
RNAs (,22 nt), which function as important regulators of a wide
range ofcellularprocessesbymodulating gene expression[20].Two
major silencing mechanisms havebeenidentified for miRs: they can
inhibit translational initiation or induce mRNA degradation [21].
Recent studies have shown that dysregulation of miR expression is
closely associated with many diseases, including obesity, type 2
diabetes and atherosclerosis [22–25]. However, the possible role of
miRs in the protective effect of adiponectin on monocytes remains
to be determined. A possible candidate is miR-146b-5p. It has been
shown that miR-146b-5p decreases the expression of TNFa in
THP-1 monocytes by the targeted repression of IRAK1 and TNF
receptor-associated factor-6 (TRAF6), two key adapter molecules in
the IRAK/NFkB pathway [26,27].
Here, we show that miR-146b-5p is decreased in circulating
monocytes of obese subjects. Functionally, miR-146b-5p is regulated
by variable globular adiponectin concentrations and acts as an
inhibitor of NFkB-mediated inflammation. Furthermore, miR-
146b-5p is necessary for the anti-inflammatory action of high levels
of globular adiponectin. In contrast, miR-146b-5p appears not to be
involved in the insulin signaling in monocytes possibly due to the
protective response of IRAK3 and lack of mROS production.
Results
Characteristics of study cohort
The study cohort comprised 14 lean controls (29% male) and 21
morbidly obese individuals (33% male), without clinical symptoms
of cardiovascular disease. Obese patients were more frequently
diabetic and treated with a statin. They had higher IL-6, high
sensitivity C-reactive protein (hs-CRP), leptin and glucose levels,
and lower adiponectin levels, indicating chronic systemic inflam-
mation. The higher levels of circulating oxidized LDL indicated
systemic oxidative stress. Furthermore, insulin and triglyceride
concentrations were higher; HDL-cholesterol was lower. Obese
individuals had higher systolic and diastolic blood pressure. Insulin
resistance, calculated by a homeostasis model assessment (HOMA-
IR), was 86% higher in obese subjects (Table 1).
miR-146b-5p is decreased in monocytes of obese
subjects and is regulated by variable adiponectin
concentrations
We determined the expression level of miR-146b-5p in isolated
monocytes of 14 lean controls and 21 obese subjects. Figure 1 illustrates
a theoretical model of the association between miR-146b-5p, NFkB-
mediated inflammation, mROS and intracellular ROS (iROS)
production and the insulin signaling by its predicted interaction with
IRAK1 and TRAF6 in monocytes. The expression of the candidate
miR was assessed by quantitative real-time PCR (qRT-PCR), and
normalized by expression levels of RNU5G, identified as most stable
reference gene (GeNorm [28]). miR-146b-5p was downregulated in
monocytes of obese subjects (Figure 2A). The expression was not
affected by gender differences. Gene expressions of key molecules in
the gene cluster are depicted in Table 2.
Previously, we showed that differential expressions of targets
within the gene cluster depended on adiponectin and glucose levels
[15]. Therefore, we determined miR-146b-5p expression levels in
response to low and high levels of anti-inflammatory and
antioxidative adiponectin and to ROS- and inflammation-
inducing high levels of glucose. As previously shown, exposure of
THP-1 cells to low levels of adiponectin resulted in a decreased
expression of IRAK3 compared to cells exposed to high levels of
adiponectin. This decrease was associated with more TNFa
(+75%, P,0.001), SOD2 (+51%, P,0.001) and mROS production
(+20%, P,0.01). The iROS production and the expression of
insulin receptor substrate-1 (IRS1) protein, a key player in the
insulin signaling [29], were not affected. Exposure to low levels of
adiponectin was associated with a decreased expression of miR-
146b-5p (Figure 2B).
Short-term exposure of THP-1 monocytes to high glucose,
comparable to those in obese patients, did not affect miR-146b-5p
expression (Figure 2C).
miR-146b-5p regulates inflammation but not oxidative
stress and insulin signaling in vitro
We transfected THP-1 monocytes with a LNA-modified miR
inhibitor that targets miR-146b-5p. Depletion of miR-146b-5p in
Table 1. Characteristics of obese subjects.
Lean controls (n=14) Obese patients (n=21)
Gender (% male) 29 33
Smoking (%) 7 19
T2DM (%) 0 38
*
Statin use (%) 0 33
*
Age (years) 33633 9 63
BMI (kg/m
2)2 1 614 4 61
***
Leptin (ng/ml) 8.761.4 65.668.0
***
Adiponectin (mg/ml) 10.961.8 3.960.6
**
Glucose (mg/dl) 83621 1 1 67
***
Insulin (mU/l) 10.361.8 16.562.1
**
HOMA-IR 2.160.4 3.960.5
**
Triglycerides (mg/dl) 80671 3 2 611
***
LDL-C (mg/dl) 110698 5 66
*
HDL-C (mg/dl) 64644 9 63
**
SBP (mmHg) 120631 3 7 63
**
DBP (mmHg) 75638 6 62
**
IL-6 (pg/ml) 1.860.2 4.860.4
***
Hs-CRP (mg/l) 0.4960.10 5.6561.13
***
Ox-LDL (IU/l) 50657 1 64
**
Data shown are means 6 SEM.
*P,0.05,
**P,0.01 and,
***P,0.001 obese compared with lean controls. Abbreviations: BMI, body mass
index; C, cholesterol; DBP, diastolic blood pressure; HOMA-IR, homeostasis
model assessment of insulin resistance; hs-CRP, high sensitivity C-reactive
protein; ox-LDL, oxidized LDL; SBP, systolic blood pressure; T2DM, type 2
diabetes mellitus.
doi:10.1371/journal.pone.0032794.t001
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(Figure 3A) resulting in activation of the canonical NFkB signaling
pathway, determined as NFkB p65 DNA binding activity, and an
increased expression of TNFa (Figure 3B). The expression of
IRAK3 was decreased on RNA level but increased on protein level
(Figure 3C). We also determined the effect of miR-146b-5p
knockdown on oxidative stress and insulin signaling by measuring
ROS production and the expression levels of IRS1. The
knockdown of miR-146b-5p in THP-1 monocytes had no effect
on m- and iROS production (Figure 3D). The expression of SOD2
was decreased (236%, P,0.01) after miR-146b-5p depletion (data
not shown). Furthermore, the expression of IRS1 was decreased
on RNA level but increased on protein level (Figure 3E). The
expression of two other mediators of insulin signaling, the insulin
receptor (INSR) and IRS2, was unchanged (data not shown).
miR-146b-5p is a mediator of the anti-inflammatory
action of globular adiponectin
The association between miR-146b-5p and globular adiponec-
tin (Figure 2B) suggests that miR-146b-5p is a possible mediator of
the anti-inflammatory action of globular adiponectin. To study
this interaction, we exposed miR-146b-5p-depleted THP-1 cells to
10 mg/ml globular adiponectin. The sequestration of miR-146b-
5p and subsequent exposure to high levels of globular adiponectin
Figure 1. Theoretical model showing the interaction between miR-146b-5p, NFkB-mediated inflammation, ROS production and the
insulin signaling. Activation of monocytes in the circulation is characterized by increased activation of the inflammatory toll-like receptor-2 (TLR2)/
NFkB signaling pathway. Activation of this pathway will elicit pro-inflammatory cytokine release (e.g. tumor necrosis factor a (TNFa)), mitochondrial
and intracellular ROS production and impairment of the insulin sensitivity at the molecular level. More mitochondrial ROS production is associated
with an increased expression of the mitochondrial antioxidant superoxide dismutase-2 (SOD2), suggesting that SOD2 only acts as mitochondrial stress
marker (indicated as dotted line). The formed ROS will not only induce the IKK complex phosphorylation and thereby the translocation of NFkB but
will also lead to inhibition of the insulin receptor signaling pathway. Interestingly, interleukin-1 receptor-associated kinase-3 (IRAK3) and miR-146b-5p
are located upstream of the transcription factor NFkB and negatively regulates TLR signaling. IRAK3 prevents the dissociation of IRAK1 and IRAK4
from MyD88 and formation of IRAK-TRAF6 complexes. miR-146b-5p, on the other hand, inhibits the translation of IRAK1 and TRAF6. Flow of the
pathway at the protein interaction level is indicated by black arrows. Blunted arrows indicate inhibition. Phosphorylation is indicated by a circledP .
doi:10.1371/journal.pone.0032794.g001
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protein), IRAK3 protein and iROS (Figure 4A–C). The mROS
production was not affected (Figure 4C). The IRS1 expression was
decreased on RNA level but increased on protein level (Figure 4D).
Furthermore, the INSR RNA expression was unchanged and IRS2
RNA levels were increased (+16%, P,0.01).
Discussion
Although recent evidence shows that adiponectin enhances
insulin sensitivity and protects against chronic inflammation and
oxidative stress in monocytes, the involvement of miRs in these
protective effects of adiponectin has yet to be determined [15,30].
We previously identified in monocytes of obese subjects IRAK3 as
downregulated inhibitor of IRAK/NFkB-mediated chronic in-
flammation that is associated with oxidative stress and loss of
protective properties of globular adiponectin [15]. In the present
study, we identified miR-146b-5p as downregulated miR in
monocytes of obese subjects with targets in the IRAK/NFkB-
related gene cluster. We identified obesity-associated low levels of
globular adiponectin as cause of the decrease in miR-146b-5p. In
addition, miR-146b-5p is necessary for the anti-inflammatory
Figure 2. miR-146b-5p expression is decreased in monocytes of obese subjects and is regulated by globular adiponectin. (A) miR-
146b-5p expression levels in isolated monocytes from 14 lean controls and 21 obese subjects as determined by qRT-PCR analysis. Data are expressed
as means.
**P,0.01 obese compared with lean controls. miR-146b-5p expression levels determined by qRT-PCR in THP-1 cells exposed to (B)1o r
10 mg/ml globular adiponectin for 24 h (n=6), and (C) 5.5 mM D-glucose and 9.5 mM D-mannitol (osmotic control) or 15 mM D-glucose for 24 h
(n=6). Data shown are means 6 SEM.
*P,0.05 compared with THP-1 cells exposed to 10 mg/ml globular adiponectin.
doi:10.1371/journal.pone.0032794.g002
Table 2. Gene expressions in monocytes of obese subjects.
Lean controls (n=14) Obese patients (n=21)
INSR 0.9960.04 0.6560.02
***
IRAK1 0.9960.04 1.2160.04
***
IRAK3 0.9860.04 0.4960.03
***
IRS1 1.0060.18 0.9360.15
IRS2 1.0560.16 1.0160.06
NEMO 1.0060.09 1.3660.04
***
NFkB1 1.0160.05 0.9260.03
SOD2 1.0060.05 2.6560.28
***
TLR2 0.9960.08 1.5460.06
***
TNFa 1.0560.09 2.1860.31
***
TRAF6 0.9860.32 2.2660.25
***
Data shown are means 6 SEM.
***P,0.001 obese compared with lean controls.
doi:10.1371/journal.pone.0032794.t002
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depicted in Figure 1, we expected that silencing of miR-146b-5p
would also lead to an increased ROS production and impaired
insulin signaling. However, miR-146b-5p silencing did not have
these effects most likely because in response to the downregulation
of miR-146b-5p, IRAK3 was upregulated resulting in normaliza-
tion of the mROS production and an increased IRS1 expression.
The normalization of mROS was associated with a decrease in
SOD2 expression, which is in agreement with our previous data
where we show that increased mROS is associated with more
SOD2 [15]. In aggregate, our current data together with our
previous data [15] suggest that the combination of IRAK3 and
miR-146b-5p is required for an optimal inhibition of TNFa-
mediated inflammation, m- and iROS production and improved
insulin signaling. In the absence of miR-146-5p, upregulation of
IRAK3 can prevent mROS production associated with adequate
IRS1 expression even in the presence of TNFa activation.
Mechanistically, miRs have been implicated as negative
regulators of inflammatory processes at the post-transcriptional
level [27]. Dysregulation of miR expression is associated with
obesity and has profound effects on the onset and progression of
associated metabolic disorders [25,31]. miR-146b-5p is located on
chromosome 10 and its expression is dependent on NFkB. It has
been shown that miR-146b-5p decreases the expression of TNFa,
IL-1b and IL-6 in THP-1 monocytes by the targeted repression of
IRAK1 and TRAF6, two key adapter molecules in the IRAK/
NFkB pathway [26,27]. Moreover, miR-146b-5p is induced by the
anti-inflammatory lipid mediator resolvin D1 in human macro-
phages implying that this miR is a key player in the resolution of
inflammation by mediating the removal of components of the
NFkB signaling pathway [32]. Furthermore, miR-146 is highly
upregulated in monocytes during endotoxin tolerance and acts as a
tuning mechanism to prevent an overstimulated inflammatory
state [33]. The observed increase in NFkB p65 DNA binding
activity and TNFa expression in miR-146b-5p-depleted THP-1
cells despite the increase in IRAK3 protein suggests that miR-
146b-5p is a crucial negative regulator of the IRAK/NFkB
pathway in monocytes. In contrast, the ROS production was
unchanged after miR-146b-5p inhibition and the protein expres-
sion level of IRS1 was even increased. We hypothesize that this
beneficial effect is due to the increase in IRAK3 protein and that
the additional loss of IRAK3, as observed in obese patients, will
increase ROS production and decrease insulin sensitivity in
monocytes [15,19].
The role of miR-146b-5p in protection against inflammation
was further supported by the finding that after sequestration of
miR-146b-5p the cells lost their potency to raise their anti-
inflammatory action in response to high levels of adiponectin. The
insulin sensitizing action of adiponectin was improved after
knockdown of miR-146b-5p, possibly due to the increase in
IRAK3. The loss of anti-inflammatory properties after miR-146b-
5p depletion is also important in regard of adversative findings
about the protective effects of adiponectin. Indeed, previous
reports indicate that adiponectin suppresses inflammatory re-
sponses induced by hyperglycemia or TNFa [34,35], while others
have reported that adiponectin promotes inflammatory cytokine
production and is associated with a significant increase in
cardiovascular disease mortality in patients with metabolic diseases
[36–39].
In summary, we have demonstrated a bidirectional relation
between globular adiponectin and miR-146b-5p in monocytes: the
expression level of miR-146b-5p is regulated by globular
adiponectin and miR-146b-5p, at his turn, is necessary for the
anti-inflammatory action of high levels of globular adiponectin. If
deletion of miR-146b-5p leads to an increase of IRAK3, mROS
production and insulin signaling appear to be controlled even in
the presence of TNFa-mediated inflammation.
Materials and Methods
Materials
All chemicals were obtained from Sigma-Aldrich (Bornem,
Belgium), unless stated otherwise. Monoclonal antibodies against
b-ACT (13E5), IRAK1 (D51G7), IRS1 (D23G12) and TRAF6
(D21G3) were purchased from Cell Signaling Technology (Bioke ´,
Leiden, Netherlands), and polyclonal anti-IRAK3 antibody from
Rockland (Tebu-bio, Boechout, Belgium). Human THP-1 mono-
cytic cells (TIB-202) were obtained from ATCC (LGC Standards,
Molsheim, France).
Patients and ethics statement
This study complies with the Declaration of Helsinki and the
Medical Ethics Committee of the KU Leuven approved the study
protocol. All human participants gave written informed consent.
The patient cohort comprised 14 lean control (29% male;
WCF,80 cm) and 21 obese individuals (33% male; WCF:
128611 cm, mean 6 SEM). The samples were collected at the
Division of Endocrinology between March 29
th, 2005 and May
30
th, 2006. All participants were without symptoms of clinical
atherosclerotic cardiovascular disease.
Isolation of human monocytes
Blood samples were collected and after removal of the plasma
fraction, peripheral blood mononuclear cells (PBMCs) were
isolated using gradient separation on Histopaque-1077. Cells were
washed three times in Ca
2+- and Mg
2+-free Dulbecco’s (D)-PBS.
PBMCs were incubated with CD14 microbeads (20 ml/1610
7
cells) for 15 min at 4uC. Cells were washed once and re-suspended
in 500 mlC a
2+- and Mg
2+-free DPBS containing 0.5% BSA/
1610
8 cells. The suspension was then applied to an LS column in
a MidiMACS Separator (Miltenyi, Leiden, Netherlands) [40,41].
We selected CD14
+ monocytes because CD14 intensity expression
on circulating monocytes was found to be associated with
increased inflammation in patients with diabetes [42].
Blood analysis
Human blood samples were centrifuged to prepare plasma
samples for analysis. Total and HDL-cholesterol and triglyceride
levels were determined with enzymatic methods (Boehringer
Ingelheim, Mannheim, Germany). LDL-cholesterol levels were
calculated with the Friedewald formula. Insulin resistance was
calculated by a homeostasis model assessment (HOMA-IR)=fast-
ing plasma insulin (mU/l)6fasting blood glucose (mM)/22.5.
Plasma glucose was measured with the glucose oxidase method (on
Figure 3. miR-146b-5p regulates inflammation in THP-1 monocytes. (A) IRAK1 and TRAF6 protein levels, (B)N F kB p65 DNA binding activity
and TNFa RNA levels, (C) IRAK3 RNA and protein levels, (D) m- and iROS production and (E) IRS1 RNA and protein levels in THP-1 cells transfected
with miR-146b-5p inhibitor as determined by qRT-PCR, ELISA, Western blotting and flow cytometry. Data are expressed as means 6 SEM. n=6.
*P,0.05 and
**P,0.01 compared with THP-1 cells transfected with negative control miRNA. Abbreviations: iROS, intracellular ROS; mROS,
mitochondrial ROS; ROS, reactive oxygen species.
doi:10.1371/journal.pone.0032794.g003
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and insulin with an immunoassay (Biosource Technologies,
Invitrogen, Gent, Belgium). Ox-LDL [43] (Mercodia, Uppsala,
Sweden), adiponectin, leptin and IL-6 were measured with ELISA
(R&D Systems, Oxon, UK). Hs-CRP was measured on an
Immage 800 Immunochemistry System (Beckman Coulter,
Suarle ´e, Belgium). Blood pressure was taken three times with the
participant in a seated position after 5 minutes quiet rest. The
average of the last two measurements was used for systolic and
diastolic blood pressure.
RNA isolation and qRT-PCR analysis
Total RNA was extracted with TRIzol reagent (Invitrogen) and
purified on miRNeasy Mini Kit columns (Qiagen, Venlo,
Netherlands). The RNA quality was assessed with the RNA
6000 Nano assay kit using the Agilent 2100 Bioanalyzer; all
samples achieved an RNA Integrity Number (RIN) score more
than 8.0.
Total RNA (25 ng) was reverse transcribed in 20 ml reactions
using the miRCURY LNA Universal RT miR cDNA synthesis kit
(Exiqon, Vedbæk, Denmark), and the cDNA was diluted 80-fold.
Each PCR was carried out in duplicate on a 7500 Fast Real-Time
PCR system (Applied Biosystems, Gent, Belgium) in a total volume
of 20 ml by using 8 ml of the diluted cDNA, 2 ml of LNA PCR
primer set (hsa-miR-146b-5p: Exiqon, catalog no. 204553) and
10 ml of miRCURY LNA SYBRGreen master mix (Exiqon)
according to the manufacturer’s instructions. RNU5G was
determined as most stable reference gene for each sample
(GeNorm [28]). The relative gene expression was calculated by
comparing cycle times for target PCR using the following
equation: relative gene expression=2
2(DCtsample—DCtcontrol).
For investigation of mRNA expressions, total RNA (0.5 mg) was
reverse transcribed using SuperScript VILO cDNA synthesis kit
(Invitrogen) as recommended by the manufacturer. The cDNA
was diluted 50-fold. Primers used for qRT-PCR analysis are
shown in Supplementary Table S1. PCR was performed with Fast
SYBRGreen master mix (Applied Biosystems). Data were
normalized to the housekeeping gene b-ACT as previously
described [44].
Cell culture
Human THP-1 monocytic cells were subcultured in RPMI
1640 (Gibco, Invitrogen) as described previously in detail [15,44].
For globular adiponectin incubation experiments, cells were
cultured at a density of 1610
6 cells/ml in RPMI 1640
supplemented with 10% FBS and 5 mg/ml gentamicin. After
24 h, 1 or 10 mg/ml globular adiponectin (PeproTech, London,
UK) was added and the cells were incubated for 6 to 24 h.
Globular adiponectin is a recombinant protein derived from
human globular domain adiponectin cDNA expressed in Esche-
richia coli. This protein was endotoxin free (,2 EU/mg) according
to the manufacturer. For glucose incubation experiments, cells
were cultured at a density of 1610
6 cells/ml in glucose-free RPMI
1640 supplemented with 10% FBS, 5 mg/ml gentamicin, and
5.5 mM D-glucose in a 5% CO2 incubator at 37uC. After 24 h,
9.5 mM D-glucose or 9.5 mM D-mannitol (osmotic control) was
added and incubated for 24 h under normal growth conditions.
Cell viability, as determined by trypan blue exclusion, was .80%.
Cell transfection
THP-1 cells were transiently transfected with a chemical
synthesized mIRCURY LNA miR-146b-5p Power Inhibitor (59-
GCCTATGGAATTCAGTTCTC-39, Exiqon). As negative con-
trol, we used miRCURY LNA miR Power Inhibitor Control (59-
GTGTAACACGTCTATACGCCCA-39, Exiqon). Cells were
transfected with 50 nM of miR inhibitor using HiPerfect reagent
(Qiagen), according to the manufacturer’s instructions with some
modifications. Briefly, THP-1 cells were seeded at a density of
1.5610
5/well (24-well plate) in 100 ml of growth medium. Next,
complexes (3 pmol of miR inhibitor plus 6 ml of HiPerfect reagent)
were formed in 0.1 ml of serum-free RPMI-1640 for 10 min at
room temperature and then added to each well. After 6 h of
incubation under normal growth conditions, 400 ml of growth
medium was added to each well and the cells were incubated for
42 h. miR-146b-5p-depleted THP-1 cells were exposed to
globular adiponectin as mentioned above.
Mitochondrial and intracellular ROS detection
To detect mitochondrial and intracellular ROS (mROS and
iROS respectively) formation in treated THP-1 cells, measure-
ments of MitoSOX Red and CellROX Deep Red (Invitrogen)
fluorescence were performed by flow cytometry (Becton, Dick-
inson and Company, Aalst, Belgium). Cells were incubated with
PBS containing 5 mM MitoSOX for 10 min or 2.5 mM CellROX
for 30 min at 37uC and 5% CO2. The labeled cells were washed
twice with PBS and then suspended in warm PBS for analysis by
flow cytometry.
NFkB p65 DNA binding activity
NFkB p65 DNA binding activity was assessed on isolated
nuclear extracts of transfected THP-1 monocytes by ELISA using
the TransAM NFkB p65 transcription factor assay kit according to
the manufacturer’s protocol (Active Motif, La Hulpe, Belgium).
Briefly, 2 mg of nuclear extract diluted in complete lysis buffer was
used in the p65 binding assay. The samples (in duplicate) were
shaken for 1 h at room temperature in 30 ml binding buffer. After
washing, anti-p65 antibody diluted 1:1000 was applied to the wells
for 1 h at room temperature. Specific binding was estimated by
spectrophotometry after incubation with a horseradish peroxidase-
conjugated antibody (1 h at room temperature, 1:1000 diluted) at
450 nm wave length.
Cytometric bead array (CBA) analysis of TNFa cytokine
levels
Conditioned medium was harvested after centrifugation of
treated THP-1 monocytes. Quantification of levels of soluble
TNFa protein in the conditioned medium was performed using
CBA Human TNFa Flex Set kit according to the manufacturer’s
instructions (Becton, Dickinson and Company). Briefly, undiluted
medium was incubated with TNFa capture beads for 1 h at room
temperature. Next, PE-conjugated detection antibody was added
to the medium and the mixture was incubated for 1 h at room
Figure 4. miR-146b-5p inhibition prevents the anti-inflammatory action of globular adiponectin. (A) TNFa RNA levels and soluble TNFa
protein levels, (B) IRAK3 RNA and protein levels, (C) m- and iROS production, (D) IRS1 RNA and protein levels in THP-1 cells exposed to 10 mg/ml
globular adiponectin with (n=4) or without (n=6) inhibition of miR-146b-5p. Data shown are means 6 SEM.
*P,0.05,
**P,0.01 and
***P,0.001
compared with THP-1 cells exposed to 10 mg/ml globular adiponectin without miR-146b-5p inhibition. Abbreviations: iROS, intracellular ROS; mROS,
mitochondrial ROS; ROS, reactive oxygen species.
doi:10.1371/journal.pone.0032794.g004
miR-146b-5p, Adiponectin and Obesity
PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e32794temperature. Finally, cytokine-bound beads were washed twice,
and analyzed by flow cytometry.
Western blotting
Western blot analysis was performed with 20 mg of total protein.
Protein was electrophoresed through a 10–20% SDS-polyacryl-
amide gel (Bio-Rad, Nazareth Eke, Belgium) and transferred to a
polyvinylidene difluoride membrane (Millipore, Brussel, Belgium).
Membranes were processed according to standard Western
blotting procedures. To detect protein levels, membranes were
incubated with primary antibodies against b-ACT, IRAK1,
IRAK3, IRS1 and TRAF6. The membranes were then incubated
with horseradish peroxidase-conjugated secondary antibody
(Santa Cruz Biotechnology, Tebu-bio, Boechout, Belgium) and
developed with SuperSignal chemiluminescent substrate (Pierce,
Thermo Fisher Scientific, Aalst, Belgium). A PC-based image
analysis program was used to quantify the intensity of each band
(Bio-1D, Vilber Lourmat, Marne-la-Valle ´e, France). Data were
normalized to the housekeeping protein b-ACT.
Statistical analysis
Lean and obese subjects were compared with an unpaired t-test
(two-tailed); in vitro data were compared with the Mann–Whitney
U test (GraphPad Prism 5, GraphPad Software, La Jolla, CA,
USA). A P-value of less than 0.05 was considered statistically
significant.
Supporting Information
Table S1 Primers used in qRT-PCR.
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